ORNBV.HE
Orion Oyj B
Price history
Key metrics
Orion Oyj B has paid a dividend for 33 consecutive years and currently yields 2.17%, below its five year average. Its payout ratio is 51%. Dividend Health rates it Safe at 78 out of 99, with high confidence.
Data as of 22 Sept 2026
Next dividend
Per share
€0.90
Frequency
Final
Declared
12 Feb 2026
Ex-date
19 Oct 2026
in 27 days
Pay date
27 Oct 2026
in 35 days
Dividend health
Confidence High · Defensive profile · as of 22 Sept 2026
Total return
€10,000 invested is €33,710 today: €13,644 from the share price and €10,065 from dividends reinvested.
Total return +237.10%. Price alone returned +136.44% over the same window.
Assumes every dividend is reinvested on its ex-dividend date, before tax and dealing costs.
How it compares
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. It offers pharmaceutical products, which includes Nubeqa for the treatment of prostate cancer; Entacapone, Stalevo, Comtess, and Comtan to treat Parkinson's disease; Burana for inflammatory pain; Divina series for menopausal symptoms; Simdax for acute decompensated heart failure; Fareston for breast cancer; Quetiapine products for antipsychotic; Trexan for rheumatoid arthritis and cancer; Easyhaler product portfolio for asthma and COPD; and Dexdor, Precedex, and Dexmedetomidine products for human use. The company also provides Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, it offers veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells drugs and products manufactured by other companies. Additionally, the company provides self-care products, including non-prescription medicines, cosmetics, dietary supplements, vitamins, and skincare products. It also offers its products online. The company has a licensing agreement with Tenax Therapeutics, Inc. to develop oral levosimendan (TNX-103) for pulmonary hypertension in heart failure with preserved ejection fraction (PH-HFpEF); and Bayer for the development and commercialisation of darolutamide Nubeqa. Orion Oyj was founded in 1917 and is headquartered in Espo, Finland.
Annual dividends per share
Dividends paid in EUR · based on ORNBV.HE's fiscal years ending in December
Dividend Policy
Orion’s dividend distribution takes into account the distributable funds and the capital expenditure and other financial requirements in the medium and long term to achieve the financial objectives.
Dividend History
| Ex-Date | Amount | Status |
|---|---|---|
| 19 Jul 272027-07-19 | €0.9000 | Estimated |
| 22 Mar 272027-03-22 | €0.9000 | Estimated |
| 19 Oct 262026-10-19 | €0.9000 | Declared |
| 25 Mar 262026-03-25 | €0.9000 | Paid |
| 15 Oct 252025-10-15 | €0.8200 | Paid |
| 04 Apr 252025-04-04 | €0.8200 | Paid |
| 15 Oct 242024-10-15 | €0.8100 | Paid |
| 21 Mar 242024-03-21 | €0.8100 | Paid |
| 23 Mar 232023-03-23 | €1.6000 | Paid |
| 24 Mar 222022-03-24 | €1.5000 | Paid |
| 26 Mar 212021-03-26 | €1.5000 | Paid |
| 07 May 202020-05-07 | €1.5000 | Paid |
| 27 Mar 192019-03-27 | €1.5000 | Paid |
| 21 Mar 182018-03-21 | €1.4500 | Paid |
| 23 Mar 172017-03-23 | €1.3500 | Paid |
| 22 Mar 172017-03-22 | €0.2000 | Paid |
| 23 Mar 162016-03-23 | €1.3000 | Paid |
| 25 Mar 152015-03-25 | €1.3000 | Paid |
| 26 Mar 142014-03-26 | €1.2500 | Paid |
| 20 Mar 132013-03-20 | €1.3000 | Paid |
| 21 Mar 122012-03-21 | €0.1200 | Paid |
| 20 Mar 122012-03-20 | €1.3000 | Paid |
| 01 Apr 112011-04-01 | €0.0600 | Paid |
| 31 Mar 112011-03-31 | €1.2000 | Paid |
| 25 Mar 102010-03-25 | €0.1000 | Paid |
| 24 Mar 102010-03-24 | €1.0000 | Paid |
| 24 Mar 092009-03-24 | €0.9500 | Paid |
| 26 Mar 082008-03-26 | €1.0000 | Paid |
| 03 Apr 072007-04-03 | €1.0000 | Paid |
| 22 Mar 062006-03-22 | €0.7433 | Paid |
| 23 Mar 052005-03-23 | €0.4809 | Paid |
| 15 Sept 042004-09-15 | €1.8713 | Paid |
| 23 Mar 042004-03-23 | €0.2623 | Paid |
| 12 Dec 032003-12-12 | €0.6558 | Paid |
| 28 Mar 032003-03-28 | €0.4066 | Paid |
| 16 Apr 022002-04-16 | €0.4809 | Paid |
| 30 Mar 012001-03-30 | €0.5247 | Paid |
| 31 Mar 002000-03-31 | €0.2623 | Paid |
| 09 Apr 991999-04-09 | €0.4345 | Paid |
| 21 Apr 981998-04-21 | €0.5014 | Paid |
| 22 Apr 971997-04-22 | €0.2388 | Paid |
| 23 Apr 961996-04-23 | €0.1910 | Paid |
This page is for informational purposes only and does not constitute investment advice. Past dividend payments are not a guarantee of future payments. All data is sourced from public market data and may be delayed. Always do your own research before making any investment decisions.
Your dividend income, mapped.
Free for up to 25 holdings. No credit card. Import your first portfolio in under a minute.
Get started free